Sunday, October 23, 2011: 6:30 PM
Grand Ballroom AB (Hyatt Regency Chicago)
| Category Reference |
| BEC | Behavioral Economics |
ESP | Applied Health Economics, Services, and Policy Research |
| DEC | Decision Psychology and Shared Decision Making |
MET | Quantitative Methods and Theoretical Developments |
* Candidate for the Lee B. Lusted Student Prize Competition
Poster Board #
3
(ESP)
THE INFLUENCE OF PATIENT/PROVIDER BEHAVIOR ON THE VALUE OF ERCC1 TESTING RESEARCH IN STAGE II NON-SMALL CELL LUNG CANCER
Joshua A. Roth, MHA1, Josh J. Carlson, PhD1, Lotte Steuten, PhD2, Scott Ramsey, MD, PhD3 and David L. Veenstra, PharmD, PhD1, (1)University of Washington, Seattle, WA, (2)University of Twente, AE Enschede, Netherlands, (3)Fred Hutchinson Cancer Research Center/ University of Washington, Seattle, WA
4
(ESP)
*
A COST-UTILITY ANALYSIS COMPARING CONTINUOUS POSITIVE AIRWAY PRESSURE, ORAL APPLIANCE, AND SURGERY WHEN TREATING MODERATE OBSTRACTIVE SLEEP APNEA IN MIDDLE-AGED CANADIAN MALES
George Tomlinson, PhD1, Tetyana B. Kendzerska, MD, MSc1, Natasha Nanwa, MSc1, Robert A. Fowler, MD, MSc2 and Colin Shapiro, MD, PhD1, (1)University of Toronto, Toronto, ON, Canada, (2)Sunnybrook Health Sciences Center, Toronto, ON, Canada
5
(ESP)
OPTIMIZATION OF FOLLOW-UP SCENARIOS FOLLOWING BREAST CANCER
Maarten J. IJzerman, PhD1, Sabine Siesling, PhD1, Joost Klaase, MD, PhD2 and Erwin Hans, PhD1, (1)University of Twente, Enschede, Netherlands, (2)Medisch Spectrum Twente, Enschede, Netherlands
8
(ESP)
HEALTH CARE COMMISSIONING IN THE ENGLISH NHS: EVIDENCE, CO-PRODUCTION AND QUALITY OF DECISIONS
Aileen Clarke, MD, MRCGP, FFPH1, Penny Mills, BA1, Sian Taylor-Phillips, PhD1, John Powell, PhD, FFPH1, Emmanoiul Gkeredakis, PhD2, Claudia Roginski, BSc2, Harry Scarbrough, PhD2, Davide Nicolini, PhD2 and Jacky Swan, PhD2, (1)Warwick Medical School, University of Warwick, Coventry, United Kingdom, (2)Warwick Business School, University of Warwick, Coventry, United Kingdom
10
(ESP)
IS A BIRD IN THE HAND WORTH MORE THAN THREE IN THE BUSH? THE COMPARATIVE EFFECTIVENESS AND COST-EFFECTIVENESS OF CONJUGATE PNEUMOCOCCAL VACCINE PROGRAM OPTIONS IN ONTARIO, CANADA
Beate Sander, RN, MBA, MEcDev1, Anne Wormsbecker, MD2, Jeff Kwong, MD, MSc3, Gillian Lim, MSc1, Allison McGeer, MD4, Dylan Pillai, MD, PhD1 and Shelley Deeks, MD, MHSc1, (1)Ontario Agency for Health Protection and Promotion, Toronto, ON, Canada, (2)The Hospital for Sick Children, Toronto, ON, Canada, (3)Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, (4)Mount Sinai Hospital, Toronto, ON, Canada
11
(ESP)
COST-EFFECTIVENESS OF A HYPOTHETICAL INTERVENTION TO IMPROVE PHYSICIAN COMPLIANCE WITH TRAUMA TRIAGE GUIDELINES
Deepika Mohan, MD, MPH, Amber E. Barnato, MD, MPH, MS, Matthew R. Rosengart, MD, MPH, Derek C. Angus, MD, MPH, FRCP and Kenneth Smith, MD, MS, University of Pittsburgh School of Medicine, Pittsburgh, PA
12
(ESP)
COST-EFFECTIVENESS OF ADULT PNEUMOCOCCAL CONJUGATE VACCINATION IN 50-YEAR-OLDS
Kenneth J. Smith, MD, MS1, Angela Wateska, MS1, M. Patricia Nowalk, PhD2, Mahlon Raymund, PhD2, Pekka Nuorti, MD, DSc3 and Richard K. Zimmerman, MD, MPH2, (1)University of Pittsburgh, Pittsburgh, PA, (2)University of Pittsburgh School of Medicine, Pittsburgh, PA, (3)University of Tampere, Tampere, Finland
13
(ESP)
*
BALANCING CARDIAC RISK AND IMMUNOLOGIC BENEFITS IN DECISIONS ON HIV ANTIRETROVIRAL TREATMENT INITIATION
Diana M. Negoescu, BSE1, Douglas K. Owens, MD, MS2, Margaret L. Brandeau, PhD1 and Eran Bendavid, MD1, (1)Stanford University, Stanford, CA, (2)Veterans Affairs Palo Alto Health Care System and Stanford University, Stanford, CA
14
(ESP)
CLINICAL DECISION SUPPORT TO PROMOTE SAFE PRESCRIBING TO WOMEN OF REPRODUCTIVE AGE: DIFFERENTIAL EFFECTS BY SUBGROUP
Sara M. Parisi, MS, MPH1, Eleanor Bimla Schwarz, MD, MS1, Steven M. Handler, MD, PhD1, Gideon Koren, MD2 and Gary S. Fischer, MD1, (1)University of Pittsburgh, Pittsburgh, PA, (2)Hospital for Sick Children, Toronto, ON, Canada
15
(ESP)
DIAGNOSTIC VALUE OF IMAGING IN SYSTEMIC EMBOLISM
Monvadi Srichai, MD1, Robert Donnino, MD1, Ruth Lim, MD1, Amelia Wnorowski, MD2, Ambika Nayar, MD1 and R. Scott Braithwaite, MD, MSc, FACP3, (1)NYU School of Medicine, New York, NY, (2)University of Pennsylvania, Philadelphia, PA, (3)New York University School of Medicine, New York, NY
16
(ESP)
*
THE PRICE OF EMERGENCY CONTRACEPTION IN THE UNITED STATES: WHAT IS THE COST-EFFECTIVENESS OF ULIPRISTAL ACETATE VERSUS SINGLE DOSE LEVONORGESTREL?
Lisa L. Bayer, MD1, Alison B. Edelman, MD, MPH1, Aaron B. Caughey, MD, MPP, MPH, PhD2 and Maria I. Rodriguez, MD, MPH3, (1)Oregon Health & Science University, Portland, OR, (2)Oregon Health & Sciences University, Portland, OR, (3)Oregon Health and Science University, Portland, OR
17
(ESP)
IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?
Sandjar Djalalov, PhD, St. Michael's Hospital, Toronto, ON, Canada, Jaclyn Beca, St. Michael's, Toronto, ON, Canada and Jeffrey Hoch, PhD, Cancer Care Ontario, Toronto, ON, Canada
18
(ESP)
DO PATIENT-REPORTED OUTCOMES CONTRIBUTE TO REGULATORY DECISIONS IN THE USA AND EUROPE? A SYSTEMATIC REVIEW OF GUIDANCE DOCUMENTS AND AUTHORIZATIONS OF MEDICINAL PRODUCTS FROM 2006 TO 2010
Benoit Arnould, PhD1, Martine Caron, PhD2, Marie-Pierre Emery2, Patrick Marquis, MD3 and Catherine Acquadro, MD2, (1)Mapi Values, Lyon, France, (2)Mapi Research Trust, Lyon, France, (3)Mapi Values, Boston, MA
19
(ESP)
COVERAGE WITH EVIDENCE DEVELOPMENT IN ONTARIO: EXPERIENCE WITH DESIGNING FIELD EVALUATIONS TO INFORM HEALTH POLICY DECISIONS
James M. Bowen, BScPhm, MSc1, Daria J. O'Reilly, PhD, MSc2, Jean-Eric Tarride, PhD, MA2, Feng Xie, PhD2, Gordon Blackhouse, MSc.2, Robert Hopkins, MA2, Natasha Burke, BSc2, Erica Nunes3 and Ron Goeree, MA2, (1)St. Joseph's Healthcare Hamilton/McMaster University, Hamilton, ON, Canada, (2)McMaster University, Hamilton, ON, Canada, (3)St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada
21
(ESP)
THE ROLE OF MEDICAL SUPPORT PERSONNEL IN PREEMPTIVELY CHANGING CLINICAL DECISION PROCESS
Eyal Schwartzberg, BPharm, MSc, PhD, Mickey Dudkiewicz, MD, MHA and Meir Oren, MD, MSc, MPH, Hillel Yaffe Medical Center, Hadera, Israel, Hadera, Israel
22
(ESP)
*
WITH MORE EFFECTIVE THERAPIES, SHOULD WE SCREEN FOR CHRONIC HEPATITIS C IN THE U.S.?
Shan Liu, S.M., Lauren E. Cipriano, BSc, BA, PhD, Candidate and Jeremy D. Goldhaber-Fiebert, PhD, Stanford University, Stanford, CA
23
(ESP)
RATIONAL DECISION MAKING REVISITED: INSIGHTS FROM STUDYING INDIVIDUAL HEALTHCARE FUNDING DECISIONS IN ENGLAND
Sian Taylor-Phillips, PhD1, Emmanouil Gkeredakis, PhD2, Jacky Swan, PhD3, Davide Nicolini, PhD3, John Powell, PhD, FFPH2, Claudia Roginski, BSc3, Harry Scarbrough, PhD3, Penny Mills, BA4 and Aileen Clarke, MD, FFPH, MRCGP1, (1)The University of Warwick, Coventry, United Kingdom, (2)University of Warwick, Coventry, United Kingdom, (3)Warwick Business School, University of Warwick, Coventry, United Kingdom, (4)Warwick Unviersity, Coventry, United Kingdom
24
(ESP)
GAZING INTO THE MS CRYSTAL BALL: A NOVEL PREDICTIVE TECHNIQUE FOR IDENTIFYING MS NON-ADHERENCE
Suman Katragadda, PhD, Seda Follis, MS, Anna Vlahiotis, MA, Robert F. Nease, PhD and Sharon Frazee, PhD, Express Scripts Inc, St. Louis, MO
26
(ESP)
A DISCRETE-EVENT SIMULATION MODEL TO EVALUATE COST-EFFECTIVENESS OF SMOKING CESSATION TREATMENTS
Odette Reifsnider, MS1, Maria Mayorga, MS, PhD1 and Stephanie B. Wheeler, PhD, MPH2, (1)Clemson University, Clemson, SC, (2)University of North Carolina at Chapel Hill, Chapel Hill, NC
27
(ESP)
*
CORONARY COMPUTED TOMOGRAPHY VERSUS EXERCISE TESTING IN PATIENTS WITH STABLE CHEST PAIN: COMPARATIVE EFFECTIVENESS AND COSTS
Tessa S.S. Genders, MSc1, Bart S. Ferket, MD1, Admir Dedic, MD1, Tjebbe W. Galema, MD, PhD1, Nico R. Mollet, MD, PhD1, Pim J. de Feyter, MD, PhD1, Kirsten E. Fleischmann, MD, MPH2, Koen Nieman, MD, PhD1 and M.G. Myriam Hunink, MD, PhD1, (1)Erasmus University Medical Center, Rotterdam, Netherlands, (2)UCSF Medical Center, San Francisco, CA
28
(BEC)
DECISION MAKING BIASES IN JUDGMENTS ABOUT VASCULAR RISK FACTORS
Julia Reinholz, PhD1, Bernward Winter, MSc1, Marc Linzmajer, MA2, Peter Kenning, Prof., Dr.2 and Stefan Knecht, Prof., Dr.1, (1)University of Muenster, Muenster, Germany, (2)Zeppelin University, Friedrichshafen, Germany
30
(DEC)
VALUE CLARIFICATION IN DECISION AIDS: A MISSING ELEMENT?
Nick Bansback, PhD, Stirling Bryan, PhD, Linda Li, PhD and Larry D. Lynd, PhD, University of British Columbia, Vancouver, BC, Canada
33
(DEC)
PATIENT PRIORITIES REGARDING CURRENTLY RECOMMENDED COLORECTAL CANCER SCREENING OPTIONS
James G. Dolan, MD, University of Rochester, Rochester, NY, Emily Boohaker, MD, HealthSpring of Alabama, Birmingham, AL, Jeroan Allison, MD, University of Massachusetts, Worcester, MA and Thomas F. Imperiale, MD, Indiana University School of Medicine, Indianapolis, IN
34
(DEC)
ATTITUDES TOWARDS MODE OF DELIVERY CHOICE AMONG A DIVERSE POPULATION OF PREGNANT WOMEN
Kathryn Houston, MD, MA1, Anjali Kaimal, MD, MAS2, Ann Drapkin Lyerly, MD, MA3, Margaret Olivia Little, PhD4, Aaron B. Caughey, MD, MPP, MPH, PhD5, Sanae Nakagawa, MA1 and Miriam Kuppermann, PhD, MPH1, (1)University of California, San Francisco, San Francisco, CA, (2)Massachusetts General Hospital, Harvard Medical School, Boston, MA, (3)University of North Carolina, Chapel Hill, NC, (4)Georgetown University, Washington DC, DC, (5)Oregon Health & Sciences University, Portland, OR
35
(DEC)
LITERACY AND NUMERACY IN VETERANS AND THEIR IMPACT ON CANCER TREATMENT PERCEPTIONS AND ANXIETY
Angela Fagerlin, PhD1, Margaret Holmes-Rovner, PhD2, Sara J. Knight, PhD3, Stewart Alexander, PhD4, Bruce Ling, MD, MPH5, James Tulsky, MD4, David Rovner, MD6, Julie E. Tobi, MA7, Valerie Kahn, MPH8 and Peter A. Ubel, MD9, (1)University of Michigan / Ann Arbor VA, Ann Arbor, MI, (2)Center for Ethics, E. Lansing, MI, (3)San Francisco VA Medical Center, San Francisco, CA, (4)Duke University, Durham, NC, (5)University of Pittsburgh, Pittsburgh, PA, (6)Michigan State University College of Human Medicine, East Lansing, MI, (7)MI, (8)University of Michigan, Ann Arbor, MI, (9)University of Michigan, Ann Arbor, USA
36
(DEC)
IF I'M NOT HIGH RISK, THEN THAT'S NOT MY RISK: TAILORING ESTIMATES FOR LOW-RISK PATIENTS MAY UNDERMINE PERCEIVED RELEVANCE
Brian J. Zikmund-Fisher, PhD1, Holly Witteman, PhD1, Mark Dickson, MA1 and Ethan A. Halm, MD, MPH2, (1)University of Michigan, Ann Arbor, MI, (2)University of Texas Southwestern, Dallas, TX
37
(DEC)
*
GIRLS' INTERPRETATION OF A HPV VACCINATION LEAFLET: A QUESTIONNAIRE STUDY
Robine Hofman, MSc1, Puck A.W.H. Schiffers2, Jan-Hendrik Richardus, MD, PhD3, Inge M.C.M. de Kok, PhD4, Marjolein van Ballegooijen, MD, PhD5, Peter A. Ubel, MD6 and Ida J. Korfage, PhD1, (1)Erasmus MC - University Medical Center, Rotterdam, Netherlands, (2)VU University, Amsterdam, Netherlands, (3)Erasmus MC - University Medical Centre; Municipal Public Health Service Rotterdam-Rijnmond, Rotterdam, Netherlands, (4)Erasmus MC, University Medical Center, Rotterdam, Netherlands, (5)Erasmus MC - University Medical Center Rotterdam, Rotterdam, Netherlands, (6)Duke University, Durham, NC
38
(DEC)
THE DELIVERY OF NON-EVIDENCE BASED PREVENTIVE SERVICES DURING PERIODIC HEALTH EXAMINATIONS
Deirdre A. Shires, MPH, MSW1, George Divine, PhD1 and Jennifer Elston Lafata, PhD2, (1)Henry Ford Health System, Detroit, MI, (2)Virginia Commonwealth University, Richmond, VA
39
(DEC)
COMPREHENSIVE ASSESSMENT OF MEN'S PREFERENCES FOR PROSTATE CANCER CARE
Sara J. Knight, PhD1, Eunjung Lim2, Gregory L. Green, MPH1, Melissa S. Yale, MS2, David M. Latini, PhD3, Mary-Margaret Chren, MD1 and Laura P. Sands, PhD2, (1)San Francisco VA Medical Center, San Francisco, CA, (2)Purdue University, West Lafayette, IN, (3)Michael E. DeBakey Veterans Affairs Medical Center/Baylor College of Medicine, Houston, TX
40
(DEC)
DEVELOPMENT AND VALIDATION OF A GLAUCOMA SPECIFIC UTILITY ELICITATION INSTRUMENT
Steven M. Kymes, Ph.D.1, Colleen M. Peters, M.A.1, Kathleen M. Beusterien, M.P.H2, Sameer V. Kotak, B., Pharm, M.S.3, Dustin L. Stwalley1 and Andreas Pleil, PhD3, (1)Washington University School of Medicine, Saint Louis, MO, (2)Oxford Outcomes, Washington, DC, (3)Pfizer, Inc., New York, NY
41
(DEC)
THE QUALITY OF DECISIONS ABOUT BREAST CANCER SURGERY
Clara Lee, MD, MPP1, Jeffrey K. Belkora, PhD2, Yuchiao Chang, PhD3, Beverly Moy, MD, MPH3, Ann Partridge, MD, MPH4 and Karen R. Sepucha, PhD3, (1)University of North Carolina Chapel Hill, Chapel Hill, NC, (2)University of California, San Francisco, San Francisco, CA, (3)Massachusetts General Hospital, Boston, MA, (4)Dana-Farber Cancer Institute, Boston, MA
42
(DEC)
*
DOES MESSAGE SOURCE AFFECT PARENTS' RESPONSES TO ADS PROMOTING HPV VACCINE FOR BOYS?
Jessica A. Kadis, MPH1, Paul L. Reiter, PhD2, Annie-Laurie McRee, DrPH1 and Noel T. Brewer, PhD1, (1)UNC Gillings School of Global Public Health, Chapel Hill, NC, (2)UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
44
(DEC)
ENCOUNTERS WITH “GODS ON THEIR HIGH THRONES IN HEAVEN”: PATIENT PERCEPTIONS OF WHAT IT TAKES TO PARTICIPATE IN SHARED DECISION MAKING
Dominick Frosch, PhD1, Suepattra May, PhD, MPH1, Katharine Rendle, MA, MSW1, Caroline Tietbohl, BA1 and Glyn Elwyn, MD, PhD2, (1)Palo Alto Medical Foundation Research Institute, Palo Alto, CA, (2)Cardiff University, Cardiff, United Kingdom
45
(DEC)
ASSESSING THE QUALITY OF BREAST CANCER SURGERY DECISIONS IN A NATIONAL MEDICARE SAMPLE
Karen R. Sepucha, PhD, Massachusetts General Hospital, Boston, MA, Carol Cosenza, MSW, University of Massachusetts Boston, Boston, MA and Julie Bynum, M.D., M.P.H., Dartmouth Medical School, Lebanon, NH
47
(DEC)
THE DEVELOPMENT OF A DECISION-AID TO GUIDE COUNSELING OF PARENTS FACING IMMINENT EXTREME PREMATURE DELIVERY
Ursula Guillen, MD1, Sanghee Suh, BS1, David Munson, MD1, Michael Posencheg, MD1, Elissa Truitt, MSSA, LSW1, Amiram Gafni, PhD2, John A.F Zupancic, MD, ScD3 and Haresh Kirpalani, BM, MSc1, (1)Children's Hospital of Philadelphia, Philadelphia, PA, (2)McMaster University, Hamilton, ON, Canada, (3)Harvard Medical School, Boston, MA
48
(DEC)
*
DOES DIAGNOSIS MATTER IN END-OF-LIFE DECISION MAKING IN THE HOSPITAL?
Frederika E. Witkamp, RN1, L. van Zuylen, MD, PhD2, C.C.D. van der Rijt, MD, PhD, Prof2 and A. van der Heide, MD, PhD2, (1)Erasmus MC University Medical Center, Rotterdam, Netherlands, (2)Erasmus MC University Medical Centre, Rotterdam, Netherlands
49
(DEC)
“DON'T KNOW” RESPONSES TO RISK PERCEPTION MEASURES: IMPLICATIONS FOR UNDERSERVED POPULATIONS
Erika A. Waters, PhD, MPH1, Jennifer Hay, PhD2, Heather Orom, PhD3, Marc T. Kiviniemi, PhD3 and Bettina Drake, PhD, MPH1, (1)Washington University School of Medicine, Saint Louis, MO, (2)Memorial Sloan-Kettering Cancer Center, New York, NY, (3)University at Buffalo, SUNY, Buffalo, NY
50
(DEC)
THE IMPORTANCE OF INTERACTIONS IN DETERMINING HOW COMMUNITY PRACTITIONERS DIAGNOSE AND TREAT ACUTE RESPIRATORY TRACT INFECTIONS
Robert Wigton, MD, MS1, Carol Darr, PhD2, Kitty Corbett, PhD3, Devin Nickol, MD1 and Ralph Gonzales, MD4, (1)University of Nebraska Medical Center College of Medicine, Omaha, NE, (2)University of Colorado College at Denver, Denver, CO, (3)Simon Fraser University, Burnaby, BC, Canada, (4)University of California San Francisco, San Francisco, CA
51
(DEC)
WITHDRAWN- NEUROTICISM IS ASSOCIATED WITH SELF-RATED HEALTH ON THE EQ-5D
Kim Rand-Hendriksen, Cand.Psychol1, Liv Ariane Augestad, MD1, Ivar Sønbø Kristiansen, MD, PhD, MPH2 and Knut Stavem, MD, MPH, PhD1, (1)Akershus University Hospital, Lørenskog, Norway, (2)University of Oslo, Oslo, Norway
53
(DEC)
SOURCES OF CONFLICTING MEDICATION INFORMATION: ASSOCIATIONS WITH DEMOGRAPHIC FACTORS AND MEDICATION ADHERENCE
Delesha M. Carpenter, PhD, MSPH, Emily A. Elstad, MPH, Susan J. Blalock, PhD, MPH and Robert F. DeVellis, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC
54
(DEC)
BMI, CANCER RISK PERCEPTION, AND PREVENTIVE BELIEFS
Julie M. Kapp, MPH, PhD, University of Missouri, Columbia, MO and Walton Sumner, MD, Washington University, St. Louis, MO
55
(MET)
THE EFFECT OF DIFFERENT PROPENSITY REGRESSION TECHNIQUES ON PREDICTIVE ACCURACY IN COMPARATIVE EFFECTIVENESS RESEARCH
Amy S. Nowacki, PhD, Brian J. Wells, MD, MS, Changhong Yu, MS and Michael W. Kattan, PhD, Cleveland Clinic, Cleveland, OH
56
(MET)
DETERMINING THE MOST INFORMATIVE MAMMOGRAPHIC FEATURES IN BREAST CANCER DIAGNOSIS BY MULTIDIMENSIONAL MUTUAL INFORMATION ANALYSIS AND BAYESIAN REASONING
Yirong Wu, PhD1, Oguzhan Alagoz, PhD1, Mehmet Ayvaci, MS1, David J. Vanness, Ph.D.2 and Elizabeth S. Burnside, MD, MPH, MS1, (1)University of Wisconsin-Madison, Madison, WI, (2)Department of Population Health Sciences, Madison, WI
57
(MET)
WINTDRAWN - A NOVEL JOINT HEALTH-STATE TARIFF-VALUE PREDICTOR BASED ON UNITS OF MORBIDITY
Mathias Barra, PhD1, Kim Rand-Hendriksen, Cand.Psychol2, Liv Ariane Augestad, MD2 and Knut Stavem, MD, MPH, PhD2, (1)HØKH, Lørenskog, Norway, (2)Akershus University Hospital, Lørenskog, Norway
58
(MET)
MICROSIMULATION AND CALIBRATION METHODS ACCOUNTING FOR OBESITY AND UNDERWEIGHT-RELATED HEALTH IN COUNTRIES LIKE INDIA
Stephanie L. Bailey, PhD1, Kunnambath Ramadas, MD2, Catherine Sauvaget, PhD3 and Jeremy D. Goldhaber-Fiebert, PhD1, (1)Stanford University, Stanford, CA, (2)Regional Cancer Centre, Trivandrum, India, (3)International Agency for Research on Cancer, Lyon, France
59
(MET)
AGENT-BASED APPROACH TO CONTACT PATTERNS MODELLING
Marija Zivkovic Gojovic, PhD1, Beate Sander, RN, MBA, MEcDev1, Ashleigh Tuite2 and Natasha Crowcroft, PhD1, (1)Ontario Agency for Health Protection and Promotion, Toronto, ON, Canada, (2)University of Toronto, Toronto, Ontario, Toronto, ON, Canada
